The apoB/apoA‐I ratio is considered to reflect the balance between atherogenic apoB‐containing particles and antiatherogenic high‐density lipoprotein particles.11 As such, this metric captures both dyslipidemia and dysmetabolic regulation. Here, APOA1 is linked to metabolic syndrome.